Approval · Notice of Compliance 11429 · 2010
MIDODRINE: Notice of Compliance 11429
Issued May 27, 2010
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 11429
- Date
- May 27, 2010
- Company
- AA Pharma Inc.Toronto, Ontario, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Abbreviated New Drug Submission (ANDS)
- Submission class
- Admin
- Reason
- Manufacturer and product name change
- Therapeutic class
- Vasopressor
- Canadian reference product
- AMATINE (Shire Canada Inc)
Products in this notice
Medicinal ingredients
- MIDODRINE HCL 2.5 MG per TAB
- MIDODRINE HCL 5 MG per TAB